Trius Investigator Site 104 is a clinical research site located in Oceanside, California, United States 92056.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Trius Investigator Site 104 has participated in 2 clinical trials.
Therapeutic areas: Major Cutaneous Abscess, Cellulitis, Erysipelas.
Sponsors: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Trius Investigator Site 104 has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Trius Investigator Site 104 has 2 clinical trials on record. Their work covers Major Cutaneous Abscess, Cellulitis, Erysipelas.
Trius Investigator Site 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.